The question of who should be on testosterone replacement therapy is more nuanced than a testosterone number alone can answer. Men with identical laboratory values can have very different clinical pictures — different symptoms, different health histories, different modifiable contributing factors, and different risk profiles. TRT is appropriate for some of them and premature or unnecessary for others. Understanding the criteria that distinguish a good candidate from someone who isn’t yet — or shouldn’t be — one of them is both practically important and often poorly communicated.
The clinical gatekeeping around TRT has loosened considerably over the past decade, particularly with the growth of direct-to-consumer men’s health platforms that make testosterone prescriptions more accessible than they were through traditional medical channels. That accessibility has genuine value for men who were previously undertreated. It also creates the risk of men initiating TRT before reversible causes of low testosterone have been addressed, before the diagnosis has been properly confirmed, or before the implications for fertility and long-term health management have been fully understood.
This article covers the criteria that define a genuine candidate for TRT, the factors that should be evaluated before starting, the situations where TRT may be premature, and the circumstances that represent relative or absolute contraindications. The goal is not to discourage men from pursuing appropriate treatment but to ensure that those who pursue it are doing so with an accurate understanding of their own situation.
The Core Criteria for TRT Candidacy
Clinical guidelines from major endocrinology and urology societies — including the Endocrine Society and the American Urological Association — have established criteria for diagnosing and treating hypogonadism that form the basis for TRT candidacy assessment. While these guidelines are periodically updated and not uniformly applied in practice, they represent the clearest evidence-based framework available.
Criterion One: Confirmed Low Testosterone on Repeated Testing
A single low testosterone reading is not sufficient to diagnose hypogonadism or justify TRT. Testosterone levels fluctuate significantly across the day — levels are highest in the morning and can be 20 to 30 percent lower by afternoon — and individual readings can be affected by acute illness, stress, recent alcohol consumption, poor sleep, and other transient factors. Standard clinical practice requires two separate morning testosterone measurements showing consistently low values before a diagnosis of hypogonadism is made.
The threshold for “low” varies by laboratory and guideline. Most current guidelines use 300 ng/dL as the lower boundary of normal total testosterone, though some use 264 ng/dL and others consider low-normal range (300 to 400 ng/dL) in the context of significant symptoms. Free testosterone — the biologically active fraction not bound to SHBG — is also relevant, particularly in men with total testosterone in the low-normal range but elevated SHBG, which can result in free testosterone that is genuinely deficient despite an adequate total. Our article on free versus total testosterone covers why this distinction matters clinically.
Criterion Two: Symptoms Consistent With Hypogonadism
Laboratory confirmation of low testosterone is necessary but not sufficient. The clinical guidelines are clear that TRT is indicated for symptomatic hypogonadism — low testosterone accompanied by symptoms attributable to the deficiency. A man with consistently low testosterone but no meaningful symptoms has less clinical justification for treatment than one with the same laboratory picture and significant symptomatic burden.
The symptoms most specifically associated with testosterone deficiency — and therefore most relevant to the candidacy assessment — include reduced libido, reduced spontaneous erections, loss of body hair, reduced testicular volume, hot flashes, and gynecomastia. Other symptoms, including fatigue, depressed mood, cognitive difficulties, reduced energy, and decreased muscle mass, are consistent with hypogonadism but are less specific because they have many other causes. A clinical assessment that considers the full symptom picture alongside the laboratory findings is more informative than either alone.
Criterion Three: No Untreated Reversible Cause
Before initiating TRT, a thorough evaluation should identify whether the low testosterone has a reversible underlying cause. Secondary hypogonadism — where the problem is at the level of the hypothalamus or pituitary rather than the testes — can sometimes be addressed by treating the cause rather than the testosterone deficiency directly. Common reversible or partially reversible causes include significant obesity, obstructive sleep apnea, chronic opioid or glucocorticoid use, hyperprolactinemia (elevated prolactin, often from a pituitary adenoma), thyroid dysfunction, and nutritional deficiencies.
Addressing these factors first — or simultaneously — is clinically appropriate for several reasons. It may resolve the testosterone deficiency without requiring exogenous replacement. It improves the hormonal environment in which TRT, if still needed, will work. And it identifies potentially serious underlying conditions that could be missed if testosterone is treated symptomatically without investigating its cause. Our article on what causes testosterone to drop prematurely provides context for understanding the range of potential contributors.
Who Benefits Most From TRT
Within the population of men with confirmed hypogonadism, some are likely to benefit more substantially from TRT than others. Understanding the factors associated with larger treatment response helps calibrate expectations and supports better clinical decision-making.
Men With Clearly Deficient Testosterone and Significant Symptoms
The strongest TRT candidates are men with testosterone consistently and substantially below the normal range — typically below 250 to 300 ng/dL — who are experiencing a meaningful symptom burden attributable to that deficiency. The clinical trials showing the most robust benefits from TRT have generally been conducted in populations with clearly low testosterone rather than in men at the lower boundary of normal. Larger deficits produce larger treatment responses, and men who are more significantly symptomatic have more room for clinically meaningful improvement.
Men Whose Low Testosterone Is Primary in Origin
Primary hypogonadism — where the testes themselves are unable to produce adequate testosterone despite adequate LH signaling — responds well to TRT because the limiting factor is production capacity rather than signaling. Primary hypogonadism is diagnosed when low testosterone is accompanied by elevated LH and FSH (indicating the pituitary is appropriately trying to stimulate the testes, but the testes aren’t responding). Common causes include Klinefelter syndrome, prior testicular injury or surgery, chemotherapy or radiation effects, and age-related decline in Leydig cell function.
Men Who Have Addressed Modifiable Factors Without Adequate Recovery
Men who have genuinely committed to lifestyle improvement — meaningful fat loss, sleep optimization, stress management, regular resistance training — and still show persistently low testosterone after three to six months of sustained effort are better TRT candidates than men who haven’t yet tried. This isn’t a moral judgment about lifestyle; it’s a clinical assessment of whether the testosterone deficiency reflects a reversible functional state or a more fixed underlying condition. Men who have demonstrated that their testosterone doesn’t adequately recover with lifestyle intervention have stronger grounds for medical treatment.
Older Men With Age-Related Decline
Age-related testosterone decline — sometimes called late-onset hypogonadism — is a legitimate clinical entity in which testosterone falls progressively with age due to declining Leydig cell function, reduced HPG axis activity, and accumulated lifestyle and health factors. The gradual nature of this decline and its often-subtle symptom development can make it easy to attribute to aging generally rather than to a treatable hormonal condition. Men over 50 with testosterone in the deficient range and meaningful symptoms are appropriate TRT candidates when contraindications have been evaluated and reversible factors addressed.
When TRT May Be Premature
Several situations warrant caution about initiating TRT before other steps have been taken, not because TRT would necessarily be harmful but because alternatives may be more appropriate or should be tried first.
When Reversible Causes Haven’t Been Addressed
As discussed above, men with significant obesity, untreated sleep apnea, chronic high stress, or other identifiable contributors to low testosterone who haven’t yet addressed those factors are premature TRT candidates in most cases. The exception is when the symptom burden is severe enough to warrant treatment despite ongoing lifestyle work — which is a clinical judgment rather than a categorical rule.
When Fertility Is a Current Concern
Men who want biological children now or in the near future should not start TRT without a detailed conversation about fertility implications. TRT suppresses sperm production reliably and significantly — often to levels incompatible with natural conception within months of starting treatment. While sperm production typically recovers after TRT discontinuation, recovery is not guaranteed, can take months to years, and may be incomplete in some men. Alternative treatments that stimulate natural testosterone production while preserving fertility — particularly clomiphene citrate and hCG — are often more appropriate for men in this situation.
When the Diagnosis Hasn’t Been Properly Confirmed
Men initiating TRT based on a single testosterone reading, an afternoon blood draw, or without a thorough clinical evaluation are starting treatment without adequate diagnostic foundation. This isn’t purely academic — if testosterone is not genuinely deficient, TRT doesn’t produce the symptom improvements the man is hoping for, and he has taken on the management requirements and risks of a treatment he didn’t need. Proper diagnosis matters for the likelihood of meaningful benefit.
When Symptoms Have Other Likely Explanations
Fatigue, reduced libido, mood changes, and cognitive difficulties are symptoms of many conditions beyond low testosterone, including depression, thyroid dysfunction, sleep apnea, vitamin deficiencies, and cardiovascular disease. Men whose symptoms are better explained by these conditions than by testosterone deficiency — or for whom these conditions haven’t been evaluated — may find that TRT produces incomplete or no improvement because it’s addressing the wrong problem. A thorough clinical evaluation before TRT initiation is not bureaucratic obstruction; it’s the difference between treating the actual cause and treating a symptom that shares some surface features with hypogonadism.
Contraindications to TRT
Certain conditions represent absolute or relative contraindications to TRT — situations where the risks are unacceptable or where TRT would actively worsen the underlying condition.
Prostate cancer and breast cancer in men are absolute contraindications to TRT, as both are androgen-sensitive and testosterone could stimulate growth. Men with a history of either require careful specialist evaluation before any testosterone treatment is considered, and standard TRT protocols are generally avoided in these populations. Elevated PSA without a prostate cancer workup warrants evaluation before starting TRT.
Severely elevated hematocrit — a red blood cell count above approximately 50 to 54 percent — is a contraindication because TRT further stimulates red blood cell production, increasing blood viscosity and thrombotic risk. Men with polycythemia vera or other conditions producing elevated hematocrit require evaluation before TRT.
Untreated severe obstructive sleep apnea is a relative contraindication because TRT can worsen airway obstruction, though this can be managed by treating the apnea first and monitoring closely during TRT. Severe heart failure, untreated severe hypertension, and recent cardiovascular events are relative contraindications requiring specialist input before TRT is initiated.
Men with known desire for future fertility, as discussed above, should be considered for fertility-preserving alternatives to standard TRT before committing to exogenous testosterone.
Questions Men Ask About TRT Candidacy
My testosterone is 280 ng/dL. Am I automatically a TRT candidate?
A testosterone of 280 ng/dL, confirmed on two separate morning draws, meets the laboratory criterion for hypogonadism by most current guidelines. Whether you’re a TRT candidate depends on the full picture: whether you have significant symptoms attributable to the deficiency, whether reversible contributing factors have been identified and addressed, whether your health history includes conditions that would modify the risk-benefit assessment, and whether fertility is a current consideration. The laboratory finding is necessary but not sufficient. A thorough clinical evaluation is the appropriate next step, not automatic prescription.
What if my symptoms match low testosterone but my levels are in the normal range?
This is one of the more challenging and contested areas in the TRT field. Some men experience significant symptoms at testosterone levels that fall within the lower portion of the normal range — and the normal range is wide enough that a man at 320 ng/dL may be functionally deficient relative to his own individual set point, even though he’s technically within range. Free testosterone, which may be low in the context of elevated SHBG even when total is normal, is worth evaluating. Whether TRT is appropriate in this context is a clinical judgment that requires an experienced clinician willing to consider the full picture. Our article on having low testosterone symptoms with normal lab results addresses this scenario specifically.
How do I find a doctor who takes low testosterone seriously?
Endocrinologists and urologists with a specific interest in men’s hormonal health are often the most knowledgeable specialists for this evaluation. Men’s health clinics — both in-person and online — have emerged as another route, though quality varies and the incentive structures of commercial TRT platforms warrant awareness. Primary care physicians vary considerably in their familiarity and comfort with testosterone management; finding one who takes the time for a thorough evaluation rather than a dismissive response is worth the effort. Our article on how to get a TRT prescription covers the process of seeking evaluation in more detail.
Can I try TRT temporarily to see if it helps before committing?
This is not an unreasonable approach, and some clinicians do offer time-limited TRT trials in men with borderline presentations — typically three to six months, with reassessment of symptoms and labs at the end of the trial period. The practical consideration is that stopping TRT after a trial period requires management of the HPG axis suppression that has developed during treatment, and some men find it difficult to tolerate the period of low testosterone while natural production recovers. A proper trial should include a clear protocol for what constitutes a positive response and a plan for monitoring and discontinuation if the trial doesn’t produce meaningful benefit.
Does age matter for TRT candidacy?
Age influences the clinical picture in several ways. Younger men with low testosterone are more likely to have a specific underlying cause that should be identified and addressed before TRT is considered — conditions like Klinefelter syndrome, pituitary disorders, or secondary hypogonadism from reversible factors. Fertility considerations are also typically more salient for younger men. Older men with age-related testosterone decline and confirmed deficiency are more straightforward TRT candidates in many respects, though age-related comorbidities — cardiovascular disease, prostate issues, elevated hematocrit risk — require more careful evaluation. There’s no age cutoff for TRT candidacy in either direction; what matters is the clinical picture rather than the number.
Is TRT a lifelong commitment?
For many men, it becomes one — particularly those with primary hypogonadism or significant age-related decline in testicular function, where the underlying condition causing low testosterone is not going to resolve. For others, particularly those whose low testosterone was driven by reversible factors they subsequently address, discontinuation with return to adequate natural production is possible. The honest answer is that it’s a commitment to ongoing management regardless of duration — regular monitoring, dose adjustment, and attention to side effects — rather than something that can be initiated and forgotten. Our article on whether you can stop TRT once you start covers the discontinuation question in full.